Offered at our Woodbridge office

SPRAVATO®

An FDA-approved nasal spray for adults whose depression has not improved enough after trying at least two antidepressants. You take it at our Woodbridge, Virginia office under the care of our clinical team.

A calm, smiling man relaxing at home in a bright room
Who it is for

A different approach when antidepressants have not been enough

SPRAVATO® (esketamine) is a prescription medicine approved by the FDA for adults. Your provider will help you decide if it is a good fit.

Treatment-resistant depression

For adults with major depressive disorder who have tried at least two antidepressants without enough relief. SPRAVATO® can be used on its own or together with an oral antidepressant.

Depression with suicidal thoughts

Also approved, together with an oral antidepressant, for adults with major depressive disorder who have suicidal thoughts or behaviors.

In crisis right now?

SPRAVATO® is not an emergency treatment. If you are thinking about harming yourself, call or text 988, or go to the nearest emergency room.

Your visit

What to expect at each treatment

Every SPRAVATO® session happens in our Woodbridge office, a certified treatment center. Plan for about two to three hours.

  1. 01Before you arriveAvoid eating for at least 2 hours and drinking liquids for at least 30 minutes before your appointment. Arrange for someone to drive you home.
  2. 02Check-inOur team checks your blood pressure to make sure it is safe to begin.
  3. 03Your doseYou use the nasal spray yourself while a member of our clinical team supervises.
  4. 04Rest and monitoringYou relax in the office for at least 2 hours while we monitor you and check your blood pressure again.
  5. 05Heading homeSomeone else drives you home. Do not drive or operate machinery until the next day after a restful sleep.
About the medicine

The SPRAVATO® nasal spray

SPRAVATO® comes in a single-use nasal spray device from Johnson & Johnson. You give yourself each dose, reclined slightly, while our clinical team watches and guides you.

SPRAVATO (esketamine) nasal spray logo and single-use nasal spray device
28mg

Of esketamine in each device.

2sprays

Per device, one in each nostril.

2–3devices

Per dose, depending on what your provider prescribes.

5min

Of rest between each device. Indicator dots show when each spray is delivered.

SPRAVATO® and SPRAVATO withMe are trademarks of Johnson & Johnson. Links open the manufacturer’s websites.

Treatment schedule

How often you come in

For treatment-resistant depression, the typical schedule looks like this. Your provider adjusts it based on how you are doing.

Weeks 1 to 4

Twice a week

The first month builds the foundation of your treatment.

Weeks 5 to 8

Once a week

Sessions become less frequent as treatment continues.

Week 9 and beyond

Every week or two

Your provider sets the ongoing schedule that works best for you.

Questions

Common questions

Still have questions? Call us at (703) 492-2924.

How soon might I notice a difference?
Everyone responds differently. In clinical studies of adults with treatment-resistant depression, some people saw improvement in their depressive symptoms as early as 24 hours after their first dose.
Is SPRAVATO® the same as ketamine?
SPRAVATO® contains esketamine, which is related to ketamine. It is a specific FDA-approved nasal spray for depression, and it can only be given at certified treatment centers under medical supervision.
Can I keep taking my antidepressant?
Yes, if that is right for you. For treatment-resistant depression, SPRAVATO® can be used on its own or together with an oral antidepressant. Your provider will talk with you about your current medications.
Will my insurance cover it?
Many insurance plans cover SPRAVATO®, and our team can help verify your benefits before you start.
Is there help with the cost?
Through the SPRAVATO withMe savings program, eligible patients with commercial or private insurance may pay $10 per treatment for the medicine. The program does not cover the cost of the observation period, and eligibility rules apply. Learn more by calling SPRAVATO withMe at 844-479-4846.
How is it different from NeuroStar TMS?
Both are options for depression that has not responded well enough to medication. SPRAVATO® is a medicine taken as a nasal spray, while NeuroStar TMS uses magnetic pulses and involves no medication. Your provider can help you decide which is the better fit.

Important Safety Information

SPRAVATO® can cause serious side effects, including:

  • Sedation, dissociation, and breathing problems. You may feel very sleepy, feel disconnected from yourself or your surroundings, or have trouble breathing. This is why you are monitored for at least 2 hours after each dose.
  • Abuse and misuse. SPRAVATO® carries a risk of abuse and misuse and is only available through a restricted program at certified treatment centers.
  • Increased suicidal thoughts and actions in some children, teens, and young adults taking antidepressants. SPRAVATO® is not approved for children.

Do not use SPRAVATO® if you have a blood vessel disease such as an aneurysm, an abnormal connection between veins and arteries, a history of bleeding in the brain, or an allergy to esketamine, ketamine, or any of its ingredients.

Common side effects include feeling disconnected from yourself or your surroundings, dizziness, nausea, sleepiness, a spinning sensation, decreased feeling or numbness, anxiety, lack of energy, increased blood pressure, vomiting, feeling drunk, and headache.

This is not a complete list. Talk with your provider about the benefits and risks of SPRAVATO®, and read the full Prescribing Information and Medication Guide.

Misty lake in the early morning

Ask us if SPRAVATO® is right for you.